Global Long-Acting Injectables Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Long-acting injectable (LAI) is a kind of pharmaceutical for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication. Rather than the daily pill-taking required with oral antipsychotics, LAI antipsychotics are administered by injection at two to four weeks intervals.

    The Long-Acting Injectables is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Long-Acting Injectables market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Long-Acting Injectables industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Long-Acting Injectables Market Segmentations:

    By Players:

    • Sanofi

    • Alkermes

    • GlaxoSmithKline

    • Johnson and Johnson

    • Eli Lilly

    • Otsuka

    • Pfizer

    By Types:

    • Small and Middle Sized Molecule

    • Large Sized Molecule

    By End-User:

    • Schizophrenia

    • Other Psychotic Disorders

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Long-Acting Injectables Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Long-Acting Injectables Market Size and Growth Rate of Small and Middle Sized Molecule from 2014 to 2026

      • 1.3.2 Global Long-Acting Injectables Market Size and Growth Rate of Large Sized Molecule from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Long-Acting Injectables Market Size and Growth Rate of Schizophrenia from 2014 to 2026

      • 1.4.2 Global Long-Acting Injectables Market Size and Growth Rate of Other Psychotic Disorders from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Long-Acting Injectables Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Long-Acting Injectables Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Long-Acting Injectables by Major Types

      • 3.4.1 Long-Acting Injectables Market Size and Growth Rate of Small and Middle Sized Molecule

      • 3.4.2 Long-Acting Injectables Market Size and Growth Rate of Large Sized Molecule

    4 Segmentation of Long-Acting Injectables Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Long-Acting Injectables by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Long-Acting Injectables in Schizophrenia

      • 4.4.2 Market Size and Growth Rate of Long-Acting Injectables in Other Psychotic Disorders

    5 Market Analysis by Major Regions

    • 5.1 Global Long-Acting Injectables Production Analysis by Major Regions

    • 5.2 Global Long-Acting Injectables Consumption Analysis by Major Regions

    • 5.3 Global Long-Acting Injectables Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Long-Acting Injectables Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Long-Acting Injectables Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Long-Acting Injectables Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Long-Acting Injectables Production, Import, Consumption and Export Analysis

    6 Product Commodity of Long-Acting Injectables Market in Major Countries

    • 6.1 Top 5 Export Countries in Long-Acting Injectables market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Long-Acting Injectables market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Long-Acting Injectables market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Long-Acting Injectables market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Long-Acting Injectables market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Long-Acting Injectables market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Long-Acting Injectables Landscape Analysis

    • 7.1 North America Long-Acting Injectables Landscape Analysis by Major Types

    • 7.2 North America Long-Acting Injectables Landscape Analysis by Major End-Users

    • 7.3 North America Long-Acting Injectables Landscape Analysis by Major Countries

      • 7.3.1 United States Long-Acting Injectables Market Volume and Growth Rate

      • 7.3.2 Canada Long-Acting Injectables Market Volume and Growth Rate

      • 7.3.3 Mexico Long-Acting Injectables Market Volume and Growth Rate

    8 Europe Long-Acting Injectables Landscape Analysis

    • 8.1 Europe Long-Acting Injectables Landscape Analysis by Major Types

    • 8.2 Europe Long-Acting Injectables Landscape Analysis by Major End-Users

    • 8.3 Europe Long-Acting Injectables Landscape Analysis by Major Countries

      • 8.3.1 Germany Long-Acting Injectables Market Volume and Growth Rate

      • 8.3.2 UK Long-Acting Injectables Market Volume and Growth Rate

      • 8.3.3 France Long-Acting Injectables Market Volume and Growth Rate

      • 8.3.4 Italy Long-Acting Injectables Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Long-Acting Injectables Market Volume and Growth Rate

      • 8.3.6 Spain Long-Acting Injectables Market Volume and Growth Rate

      • 8.3.7 Belgium Long-Acting Injectables Market Volume and Growth Rate

      • 8.3.8 Poland Long-Acting Injectables Market Volume and Growth Rate

      • 8.3.9 Russia Long-Acting Injectables Market Volume and Growth Rate

      • 8.3.10 Turkey Long-Acting Injectables Market Volume and Growth Rate

    9 Asia Pacific Long-Acting Injectables Landscape Analysis

    • 9.1 Asia Pacific Long-Acting Injectables Landscape Analysis by Major Types

    • 9.2 Asia Pacific Long-Acting Injectables Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Long-Acting Injectables Landscape Analysis by Major Countries

      • 9.3.1 China Long-Acting Injectables Market Volume and Growth Rate

      • 9.3.2 Japan Long-Acting Injectables Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Long-Acting Injectables Market Volume and Growth Rate

      • 9.3.4 India Long-Acting Injectables Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Long-Acting Injectables Market Volume and Growth Rate

      • 9.3.6 South Korea Long-Acting Injectables Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Long-Acting Injectables Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Long-Acting Injectables Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Long-Acting Injectables Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Long-Acting Injectables Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Long-Acting Injectables Market Volume and Growth Rate

      • 10.3.2 Brazil Long-Acting Injectables Market Volume and Growth Rate

      • 10.3.3 Nigeria Long-Acting Injectables Market Volume and Growth Rate

      • 10.3.4 South Africa Long-Acting Injectables Market Volume and Growth Rate 

      • 10.3.5 Argentina Long-Acting Injectables Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Sanofi

      • 11.1.1 Sanofi Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Alkermes

      • 11.2.1 Alkermes Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 GlaxoSmithKline

      • 11.3.1 GlaxoSmithKline Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Johnson and Johnson

      • 11.4.1 Johnson and Johnson Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Eli Lilly

      • 11.5.1 Eli Lilly Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Otsuka

      • 11.6.1 Otsuka Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Pfizer

      • 11.7.1 Pfizer Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 93 Figures and 136 Tables)

    • Figure Product Picture

    • Figure Long-Acting Injectables Market Size and Growth Rate of Small and Middle Sized Molecule from 2014 to 2026

    • Figure Long-Acting Injectables Market Size and Growth Rate of Large Sized Molecule from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Long-Acting Injectables Market Size and Growth Rate of Schizophrenia from 2014 to 2026

    • Figure Global Long-Acting Injectables Market Size and Growth Rate of Other Psychotic Disorders from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Long-Acting Injectables Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Long-Acting Injectables Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Long-Acting Injectables

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Long-Acting Injectables by Different Types from 2014 to 2026

    • Table Consumption Share of Long-Acting Injectables by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Small and Middle Sized Molecule

    • Figure Market Size and Growth Rate of Large Sized Molecule

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Long-Acting Injectables by Different End-Users from 2014 to 2026

    • Table Consumption Share of Long-Acting Injectables by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Schizophrenia

    • Figure Market Size and Growth Rate of Other Psychotic Disorders

    • Table Global Long-Acting Injectables Production by Major Regions

    • Table Global Long-Acting Injectables Production Share by Major Regions

    • Figure Global Long-Acting Injectables Production Share by Major Regions in 2014

    • Figure Global Long-Acting Injectables Production Share by Major Regions in 2018

    • Figure Global Long-Acting Injectables Production Share by Major Regions in 2026

    • Table Global Long-Acting Injectables Consumption by Major Regions

    • Table Global Long-Acting Injectables Consumption Share by Major Regions

    • Figure Global Long-Acting Injectables Consumption Share by Major Regions in 2014

    • Figure Global Long-Acting Injectables Consumption Share by Major Regions in 2018

    • Figure Global Long-Acting Injectables Consumption Share by Major Regions in 2026

    • Table North America Long-Acting Injectables Production, Import, Consumption and Export Analysis

    • Table Europe Long-Acting Injectables Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Long-Acting Injectables Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Long-Acting Injectables Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Long-Acting Injectables market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Long-Acting Injectables market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Long-Acting Injectables market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Long-Acting Injectables market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Long-Acting Injectables Consumption by Types from 2014 to 2026

    • Table North America Long-Acting Injectables Consumption Share by Types from 2014 to 2026

    • Figure North America Long-Acting Injectables Consumption Share by Types in 2014

    • Figure North America Long-Acting Injectables Consumption Share by Types in 2018

    • Figure North America Long-Acting Injectables Consumption Share by Types in 2026

    • Table North America Long-Acting Injectables Consumption by End-Users from 2014 to 2026

    • Table North America Long-Acting Injectables Consumption Share by End-Users from 2014 to 2026

    • Figure North America Long-Acting Injectables Consumption Share by End-Users in 2014

    • Figure North America Long-Acting Injectables Consumption Share by End-Users in 2018

    • Figure North America Long-Acting Injectables Consumption Share by End-Users in 2026

    • Table North America Long-Acting Injectables Consumption by Major Countries from 2014 to 2026

    • Table North America Long-Acting Injectables Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Long-Acting Injectables Consumption Share by Major Countries in 2014

    • Figure North America Long-Acting Injectables Consumption Share by Major Countries in 2018

    • Figure North America Long-Acting Injectables Consumption Share by Major Countries in 2026

    • Figure United States Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Long-Acting Injectables Consumption by Types from 2014 to 2026

    • Table Europe Long-Acting Injectables Consumption Share by Types from 2014 to 2026

    • Figure Europe Long-Acting Injectables Consumption Share by Types in 2014

    • Figure Europe Long-Acting Injectables Consumption Share by Types in 2018

    • Figure Europe Long-Acting Injectables Consumption Share by Types in 2026

    • Table Europe Long-Acting Injectables Consumption by End-Users from 2014 to 2026

    • Table Europe Long-Acting Injectables Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Long-Acting Injectables Consumption Share by End-Users in 2014

    • Figure Europe Long-Acting Injectables Consumption Share by End-Users in 2018

    • Figure Europe Long-Acting Injectables Consumption Share by End-Users in 2026

    • Table Europe Long-Acting Injectables Consumption by Major Countries from 2014 to 2026

    • Table Europe Long-Acting Injectables Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Long-Acting Injectables Consumption Share by Major Countries in 2014

    • Figure Europe Long-Acting Injectables Consumption Share by Major Countries in 2018

    • Figure Europe Long-Acting Injectables Consumption Share by Major Countries in 2026

    • Figure Germany Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Figure France Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Long-Acting Injectables Consumption by Types from 2014 to 2026

    • Table Asia Pacific Long-Acting Injectables Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Long-Acting Injectables Consumption Share by Types in 2014

    • Figure Asia Pacific Long-Acting Injectables Consumption Share by Types in 2018

    • Figure Asia Pacific Long-Acting Injectables Consumption Share by Types in 2026

    • Table Asia Pacific Long-Acting Injectables Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Long-Acting Injectables Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Long-Acting Injectables Consumption Share by End-Users in 2014

    • Figure Asia Pacific Long-Acting Injectables Consumption Share by End-Users in 2018

    • Figure Asia Pacific Long-Acting Injectables Consumption Share by End-Users in 2026

    • Table Asia Pacific Long-Acting Injectables Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Long-Acting Injectables Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Long-Acting Injectables Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Long-Acting Injectables Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Long-Acting Injectables Consumption Share by Major Countries in 2026

    • Figure China Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandLong-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Figure India Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Long-Acting Injectables Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Long-Acting Injectables Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Long-Acting Injectables Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Long-Acting Injectables Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Long-Acting Injectables Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Long-Acting Injectables Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Long-Acting Injectables Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Long-Acting Injectables Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Long-Acting Injectables Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Long-Acting Injectables Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Long-Acting Injectables Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Long-Acting Injectables Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Long-Acting Injectables Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Long-Acting Injectables Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Long-Acting Injectables Consumption Share by Major Countries in 2026

    • Figure GCC Countries Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Long-Acting Injectables Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Alkermes

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alkermes

    • Figure Sales and Growth Rate Analysis of Alkermes

    • Figure Revenue and Market Share Analysis of Alkermes

    • Table Product and Service Introduction of Alkermes

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Johnson and Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson and Johnson

    • Figure Sales and Growth Rate Analysis of Johnson and Johnson

    • Figure Revenue and Market Share Analysis of Johnson and Johnson

    • Table Product and Service Introduction of Johnson and Johnson

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Otsuka

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Otsuka

    • Figure Sales and Growth Rate Analysis of Otsuka

    • Figure Revenue and Market Share Analysis of Otsuka

    • Table Product and Service Introduction of Otsuka

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.